- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0005105

Xcute Pharmaceutical Private Limited
About Xcute Pharmaceutical Private Limited
Data last updated:
Xcute Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2019PTC325956. Its GSTIN is 23AAACX2962R1ZT (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Neeraj Gupta and Shashi Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 501 Bldg No – 2C – Wing Janki Avenue Sno – 34 Mira Bhaindar Road Bhayander East, Thane, Maharashtra, India – 401105.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.1 Lakh. For the same year it recorded a net profit of ₹500 (net margin 0.1%) and EBITDA of ₹1,000 (EBITDA margin 0.2%).
Xcute Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0005105).
Company details
Recognitions & Rankings of Xcute Pharmaceutical
Contact details
Xcute Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address501 Bldg No – 2C – Wing Janki Avenue Sno – 34 Mira Bhaindar Road Bhayander East, Thane, Maharashtra, India – 401105
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xcute Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xcute Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xcute Pharmaceutical Private Limited, buy the company report.
Financials of Xcute Pharmaceutical Private Limited
FY 2025 filings availableXcute Pharmaceutical Private Limited reported revenue of ₹6.1 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹500 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xcute Pharmaceutical Private Limited, buy the company report.
Board of directors of Xcute Pharmaceutical Private Limited
Xcute Pharmaceutical has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Gupta | Additional Director | 10 Mar 2025 | 1 Years 7 Months | Current |
| Shashi Gupta | Additional Director | 21 Mar 2025 | 1 Years 7 Months | Current |
| Archna Gupta | Additional Director | 10 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Xcute Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Makore Laboratories Private Limited | ₹6.13 Lakh (FY 2017) | -80.0% | Hyderabad, Telangana, India | |||
| Alstone Silicones Private Limited | ₹6.12 Lakh (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| Sreetech Pharma (India) Private Limited | ₹6.12 Lakh (FY 2023) | -43.0% | Hyderabad, Telangana, India | |||
| Curasion Remedies Private Limited | ₹6.11 Lakh (FY 2024) | -21.0% | Makaraba, Ahmedabad, Gujarat, India | |||
| Ampetic Pharma Private Limited | ₹6.1 Lakh (FY 2022) | 28.0% | Muzaffarpur, Bihar, India | |||
| Xcute Pharmaceutical Private Limitedthis company | ₹6.1 Lakh (FY 2024) | ₹500 | 0.1% | Thane, Maharashtra, India | ||
| Mahasulph (India) Private Limited | ₹6.09 Lakh (FY 2024) | -3.0% | Pune, Maharashtra, India | |||
| Medilexicon Pharmaceuticals Private Limited | ₹6.09 Lakh (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Morsus Remedies Private Limited | ₹6.09 Lakh (FY 2018) | 538.0% | Lucknow, Uttar Pradesh, India | |||
| Nobel Enkem Private Limited | ₹6.08 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| Blue E Tech Private Limited | ₹6.08 Lakh (FY 2019) | 119.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Xcute Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xcute Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xcute Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xcute Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACX2962R1ZT | Madhya Pradesh | Active | 02 Dec 2019 |
To see the full GST registrations and return filing status of Xcute Pharmaceutical Private Limited, buy the company report.
Recent activity
Xcute Pharmaceutical Private Limited has 6 board changes on record since 2025: 3 appointments and 3 cessations. The latest: Shashi Gupta was appointed as Additional Director on 21 Mar 2025.
Frequently asked questions
Xcute Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 May 2019 (7+ years old) and is registered under CIN U24299MH2019PTC325956.
Xcute Pharmaceutical has 3 current directors:
- Neeraj Gupta - Additional Director
- Shashi Gupta - Additional Director
- Archna Gupta - Additional Director
The latest financial statements of Xcute Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Xcute Pharmaceutical is 23AAACX2962R1ZT, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Xcute Pharmaceutical is U24299MH2019PTC325956. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xcute Pharmaceutical was incorporated on 28 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Xcute Pharmaceutical by revenue are Makore Laboratories Private Limited, Alstone Silicones Private Limited, Sreetech Pharma (India) Private Limited, Curasion Remedies Private Limited, Ampetic Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shashi Gupta was appointed as Additional Director on 21 Mar 2025. Shivam Kumar Lahariya ceased to be Director on 21 Mar 2025. Ahmad Vahid Hussain ceased to be Director on 11 Mar 2025. Xcute Pharmaceutical has 6 board changes on record in total.
Yes, Xcute Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0005105).
The registered office of Xcute Pharmaceutical is at 501 Bldg No – 2C – Wing Janki Avenue Sno – 34 Mira Bhaindar Road Bhayander East, Thane, Maharashtra, India – 401105.
Xcute Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.